U.S. flag

An official website of the United States government

NM_020166.5(MCCC1):c.208A>G (p.Lys70Glu) AND Methylcrotonyl-CoA carboxylase deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 30, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001277566.2

Allele description [Variation Report for NM_020166.5(MCCC1):c.208A>G (p.Lys70Glu)]

NM_020166.5(MCCC1):c.208A>G (p.Lys70Glu)

Gene:
MCCC1:methylcrotonyl-CoA carboxylase subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q27.1
Genomic location:
Preferred name:
NM_020166.5(MCCC1):c.208A>G (p.Lys70Glu)
HGVS:
  • NC_000003.12:g.183092474T>C
  • NG_008100.1:g.12104A>G
  • NM_001293273.2:c.44+2085A>G
  • NM_001363880.1:c.-55+2085A>G
  • NM_020166.5:c.208A>GMANE SELECT
  • NP_064551.3:p.Lys70Glu
  • NC_000003.11:g.182810262T>C
  • NR_120640.2:n.875A>G
Protein change:
K70E
Links:
dbSNP: rs750133436
NCBI 1000 Genomes Browser:
rs750133436
Molecular consequence:
  • NM_001293273.2:c.44+2085A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001363880.1:c.-55+2085A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_020166.5:c.208A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_120640.2:n.875A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Methylcrotonyl-CoA carboxylase deficiency
Synonyms:
Deficiency of methylcrotonoyl-CoA carboxylase; 3 Methylcrotonylglycinuria; 3-MCC Deficiency
Identifiers:
MONDO: MONDO:0018950; MedGen: C4551505; OMIM: PS210200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001464526Natera, Inc.
no assertion criteria provided
Uncertain significance
(Aug 30, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV001464526.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 7, 2023